眼咽型肌营养不良症肌力、功能能力、口咽功能与生活质量的纵向评估
本研究在43例经基因确诊的眼咽型肌营养不良症(OPMD)患者中,间隔20个月进行两次评估,采用固定式测力计、MRC分级、最大咬合力与等长舌肌力、MFM、10级 stair test、吞咽/咀嚼/言语任务及生活质量量表。结果显示18项指标中有8项在20个月内可检测到疾病进展,其中三角肌肌力下降幅度最大(-27%),且疾病进展与基因型或病程无关。
要点
- 固定式测力计测量的三角肌肌力在20个月内下降27%,为最敏感指标。
- 10级 stair test、MFM D1部分及/pa/最大重复率亦显示显著下降。
- SF-36生理功能维度显著恶化,但疾病进展与基因型或病程无关。
核心结论
- 尽管OPMD进展缓慢,20个月内多项指标可检测到疾病进展,三角肌肌力下降最显著,可作为未来临床试验的生物标志物。
研究设计与样本
- 全国性队列研究,43例经基因确诊的OPMD患者,间隔20个月进行两次评估,采用固定式测力计、MRC分级、最大咬合力与等长舌肌力、MFM、10级 stair test、吞咽/咀嚼/言语任务及生活质量量表。
主要发现
- 18项指标中8项在20个月内显示显著进展(均p<0.05)。
- 三角肌肌力下降-27%(范围-17%至-37%),股四头肌-14%(范围-6%至-23%),髂腰肌-12.2%,舌肌-9.9%,MRC总分-2.5%。
- 10级 stair test下降-12.5%,MFM D1部分下降-7.1%,/pa/最大重复率下降-5.3%。
- SF-36生理功能维度显著恶化(p=0.044)。
- 疾病进展与基因型或病程无显著关系(p>0.05)。
临床怎么用
- 三角肌肌力(固定式测力计)、10级 stair test、MFM D1及/pa/最大重复率可作为OPMD临床试验的结局指标。
局限性
- 样本量较小(43例),随访时间20个月,可能不足以反映更长期进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Oculopharyngeal muscular dystrophy (OPMD) is a late-onset, progressive muscle disease. Disease progression is known to be slow, but details on the natural history remain unknown. We aimed to examine the natural history of OPMD in a large nationwide cohort to determine clinical outcome measures that capture disease progression and can be used in future clinical trials. METHODS: Patients invited by their treating physicians or identified from the national neuromuscular database and invited family members were examined twice 20 months apart with fixed dynamometry; Medical Research Council (MRC) grading; maximum bite force and isometric tongue strength; Motor Function Measure (MFM); 10-step stair test; maximum swallowing, chewing, and speech tasks; and quality of life assessments. RESULTS: Disease progression was captured by 8 of 18 measures over 20 months in 43 patients with genetically confirmed OPMD. The largest deterioration was seen in deltoid muscle strength (-27% [range -17% to -37%]), followed by the quadriceps (-14% [range -6 to -23%]), iliopsoas (-12.2%), tongue (-9.9%), and MRC sum score (-2.5%). The 10-step stair test (-12.5%), MFM part D1 (-7.1%), and maximum repetition rate of /pa/ (-5.3%) showed a significant decrease as well (all p < 0.05). The Physical Functioning domain of the Short Form-36 Health Survey significantly deteriorated (p = 0.044). No relationship was found between disease progression and genotype or disease duration (p > 0.05). DISCUSSION: Despite the slow disease progression of OPMD, this study showed that several outcome measures detected progression within 20 months. Deltoid muscle strength, measured by fixed dynamometry, showed the greatest decline. These longitudinal data provide clinical outcome measures that can be used as biomarkers in future clinical trials.
引用
- Kroon RHMJM, Kalf JG, de Swart BJM, et al. Longitudinal Assessment of Strength, Functional Capacity, Oropharyngeal Function, and Quality of Life in Oculopharyngeal Muscular Dystrophy. Neurology. 2021. PMID: 34380753. doi:10.1212/WNL.0000000000012640
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。